Health In Tech (HIT)
Connects insurers, brokers, MGUs, and TPAs through eDIYBS quoting and underwriting.
$0.9999
At close+0.03 (+3.30%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 5 | 5 | 5 | 4 | 5 | 8 | 9 | 8 | 8 | 9 | 8 |
| Cost of revenue | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 4 | 4 |
| Gross profit | 4 | 4 | 4 | 4 | 3 | 4 | 5 | 6 | 5 | 4 | 5 | 4 |
| 4 | 3 | 4 | 3 | 3 | 4 | 5 | 6 | 5 | 4 | 7 | 7 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| 3 | 2 | 3 | 3 | 2 | 3 | 4 | 5 | 4 | 4 | 6 | 6 | |
| Selling & marketing | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| General & administrative | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | 3 | 3 | 3 | 4 |
| Operating income | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | −2 | −3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | −2 | −3 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 |
| Net income from continuing operations | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | −2 | −3 |
| Net income | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | −2 | −3 |
| EPS, basic | $0.01 | $0.02 | $0.00 | $0.01 | $0.01 | −$0.00 | $0.01 | $0.01 | $0.01 | −$0.01 | −$0.03 | −$0.04 |
| EPS, diluted | $0.01 | $0.02 | $0.00 | $0.01 | $0.01 | −$0.00 | $0.01 | $0.01 | $0.01 | −$0.01 | −$0.03 | −$0.04 |
| Weighted average shares, basic | 54 | 54 | 54 | 54 | 54 | 54 | 55 | 55 | 56 | 56 | 57 | 63 |
| Weighted average shares, diluted | 54 | 54 | 54 | 54 | 54 | 54 | 57 | 56 | 59 | 59 | 57 | 63 |
| EBITDA | 1 | 2 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | −2 | −3 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | −2 | −3 |